Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner‐based assessment of pain
Veterinary Record · 21.10.2023 · 193 (8)
DOI: 10.1002/vetr.3264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 26.07.2023. Verfasst von Florence Hillen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK. Hauptthemen laut MEDLINE: Hysterectomy, Cat Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Injectable non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly prescribed to queens undergoing ovariohysterectomy (OVH), but the requirement for postoperative administration is unclear and practices vary. Existing studies assessing efficacy rely on pain scoring by experienced clinicians. However, following OVH, most cats are discharged within hours of recovery.
Methods
Cats undergoing OVH were randomly assigned to two treatment groups: MEL and ROB. Cats in the MEL group ( n = 76) received meloxicam (0.2 mg/kg) and those in the ROB group ( n = 65) received robenacoxib (2 mg/kg). Owners were contacted by a blinded assessor 3 days postoperatively and asked to identify physical or behavioural changes and to assign pain scores using a numerical rating scale.
Results
More cats in the ROB group displayed abnormal behaviours than cats in the MEL group ( p = 0.03). Most owners assigned a pain score of 0 (72%) ( n = 101), but pain scores were significantly higher in the ROB group than in the MEL group ( p = 0.005). Limitation Methods of owner assessment of pain in cats have not been validated.
Conclusions
Both meloxicam and robenacoxib are effective in controlling postoperative pain. Meloxicam may have improved efficacy in certain patient populations. Applying a blanket approach to prescribing NSAIDs to cats undergoing OVH postoperatively may not be necessary. This has safety, environmental and cost implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UK.
- RSPCA Bolton Branch, Bolton, UK.
ORCID-Profile: Florence Hillen, Sally Polson, David Yates, Rachel Watkinson, Kate White
Zitieren
APA
Hillen, F., Polson, S., Yates, D., Watkinson, R., & White, K. (2023). Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner‐based assessment of pain. Veterinary Record, 193(8). https://doi.org/10.1002/vetr.3264
Vancouver
Hillen F, Polson S, Yates D, Watkinson R, White K. Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner‐based assessment of pain. Veterinary Record. 2023;193(8). doi:10.1002/vetr.3264
BibTeX
@article{Hillen2023,
author = {Hillen, Florence and Polson, Sally and Yates, David and Watkinson, Rachel and White, Kate},
title = {Robenacoxib versus meloxicam following ovariohysterectomy in cats: A randomised, prospective clinical trial involving owner‐based assessment of pain},
journal = {Veterinary Record},
year = {2023},
volume = {193},
number = {8},
doi = {10.1002/vetr.3264}
}
EUVIMED